-+ 0.00%
-+ 0.00%
-+ 0.00%

B of A Securities Maintains Buy on Regeneron Pharmaceuticals, Raises Price Target to $1030

Benzinga·11/02/2026 10:28:26
Listen to the news
B of A Securities analyst Tazeen Ahmad maintains Regeneron Pharmaceuticals (NASDAQ:REGN) with a Buy and raises the price target from $908 to $1030.